CClinicalTrials.gg
CompletedNCT02218541Updated Jul 27, 2018Results posted

Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.

An interventional study of abutment margin 0.5 mm subgingival and abutment margin 1.5 mm subgingival in Single Edentulous Space, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-27.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The study will involve placing a dental implant through a guided surgery protocol developed using 3D CT technology. Because the implant position is planned digitally using the CT data from the patient, this allows investigation of an abutment that supports the implant crown and soft tissues to be fabricated prior to implant placement. In doing so, this makes the protocol for patient care simpler and faster. In fabricating the the abutment prior to surgery, the investigators will design the abutments at different heights below the gumline to see an optimal margin height for fabrication of the abutment prior to surgery. The study hypothesis is that more often the abutment margin placed just slightly below (.5mm) the gumline will be visible about half of the time while the abutment margin placed further under the gumline (1.5mm) will be visible only about 10% of the time. The optimal outcome is that at delivery and follow-up, the abutment margin will not show intraorally.

02

Conditions studied

  • Single Edentulous Space

Browse trials for

03

In context

Mouth, Edentulous

244 studies on the registry are indexed under Mouth, Edentulous; 37 are open to participants now.

This study's enrollment of 22 is below the median of 30 across 187 interventional studies indexed under Mouth, Edentulous.

Browse Mouth, Edentulous studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,340 studies on the registry; 133 are open to participants now.

Of its 155 completed or terminated interventional studies of FDA-regulated products, 136 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • partially edentulous with single edentulous space
  • edentulous site where previous tooth has been extracted for at least two months
  • minimum of 20 teeth present
  • able to tolerate dental implant surgical and restorative procedures
  • consent to participate in clinical trial

Exclusion criteria

Exclusion Criteria:

  • asa class 3+
  • present drug use
  • is pregnant or plans to become pregnant
  • patients in need of lateral window sinus graft
  • patients in need of grafting prior to implant placement
  • patients in need of extensive grafting at time of implant placement
  • tooth is present or extracted within the last 2 months
  • history of IV bisphosphonate use or oral bisphosphonate use contraindicating dental implant therapy
  • untreated caries or periodontal disease
  • severe bruxism
  • smoker within past 6 months
  • unlikely to be able to comply with study procedures according to investigators
  • known allergy to any materials used in dental implant surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
22 participants (actual)

Study arms

  • Other
    abutment margin 0.5 mm subgingival

    when fabricating an abutment to support the crown, the margin will be placed 0.5 mm below the gumline

    Device: abutment margin 0.5 mm subgingival

  • Other
    abutment margin 1.5 mm subgingival

    when fabricating the abutment to support the crown, the margin will be placed 1.5 mm below the gumline

    Device: abutment margin 1.5 mm subgingival

Interventions

  • Deviceabutment margin 0.5 mm subgingival
  • Deviceabutment margin 1.5 mm subgingival
06

What researchers measure

Primary outcomes

  1. Number of Participants With Abutment Margin Exposure > 0

    Margin exposure of the abutment between groups at 6 months post surgery.

    Time frame: up to 6 months post surgery

Secondary outcomes

  1. Number of Participants With a Soft Tissue Response of Bleeding

    To assess the condition of the peri-implant mucosa, those with a soft tissue response of bleeding upon probing were counted. Fisher's exact test will be used after the site has been evaluated for presence of bleeding or not.

    Time frame: 6 months post surgery

  2. Number of Participants With Provisional Crown Fit at Delivery

    To assess if the Provisional Crown was able to be cemented at time of abutment connection was reported as 'Yes' or 'No.'

    Time frame: 8 weeks post surgery

07

Results

Posted Jul 27, 2018

Participant flow

Participant flow — Overall Study
MilestoneAbutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm Subgingival
Started1111
Completed59
Not completed62
Withdrew: Lost to follow-up21
Withdrew: Implant failure41

Outcome measures

PrimaryNumber of Participants With Abutment Margin Exposure > 0

Margin exposure of the abutment between groups at 6 months post surgery.

Time frame:
up to 6 months post surgery
Reported as:
Count of participants · Participants
Number of Participants With Abutment Margin Exposure > 0
ParticipantsAbutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm Subgingival
Number of Participants With Abutment Margin Exposure > 000
Statistical analysis
  • Abutment Margin 0.5 mm Subgingival vs Abutment Margin 1.5 mm Subgingival · Fisher Exact · p = 1.00 (threshold for significance will be p-value \<0.05)
SecondaryNumber of Participants With a Soft Tissue Response of Bleeding

To assess the condition of the peri-implant mucosa, those with a soft tissue response of bleeding upon probing were counted. Fisher's exact test will be used after the site has been evaluated for presence of bleeding or not.

Time frame:
6 months post surgery
Reported as:
Count of participants · Participants
Number of Participants With a Soft Tissue Response of Bleeding
ParticipantsAbutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm Subgingival
Yes bleeding38
No bleeding21
Statistical analysis
  • Abutment Margin 0.5 mm Subgingival vs Abutment Margin 1.5 mm Subgingival · Binomial · p = 0.039 (This statistical analysis applies to Yes bleeding)The statistical analysis was changed during the analysis phase but the protocol was not amended to reflect this change
SecondaryNumber of Participants With Provisional Crown Fit at Delivery

To assess if the Provisional Crown was able to be cemented at time of abutment connection was reported as 'Yes' or 'No.'

Time frame:
8 weeks post surgery
Reported as:
Count of participants · Participants
Number of Participants With Provisional Crown Fit at Delivery
ParticipantsAbutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm Subgingival
Yes35
No24
Statistical analysis
  • Abutment Margin 0.5 mm Subgingival vs Abutment Margin 1.5 mm Subgingival · Binomial · p = 1.0 (This statistical analysis applies to Yes Provisional Crown fit)The statistical analysis was changed during the analysis phase but the protocol was not amended to reflect this change

Adverse events

Collected over From the date of consent until six months after surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Abutment Margin 0.5 mm Subgingival0/11 (0%)0/11 (0%)0/11 (0%)
Abutment Margin 1.5 mm Subgingival0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Abutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm SubgingivalTotal
<=18 years000
Between 18 and 65 years9716
>=65 years246
Sex: Female, Male
Sex: Female, Male(Participants)Abutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm SubgingivalTotal
Female4812
Male7310
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Abutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm SubgingivalTotal
American Indian or Alaska Native000
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American145
White8614
More than one race000
Unknown or Not Reported112
Region of Enrollment
Region of Enrollment(Participants)Abutment Margin 0.5 mm SubgingivalAbutment Margin 1.5 mm SubgingivalTotal
United States111122
08

Study locations

1 site
  • Graduate Prosthodontic Clinic, Dept. of Prosthodontics, UNC School of Dentistry
    Chapel Hill, North Carolina 27599, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 4, 2014

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02218541
Lead sponsor
University of North Carolina, Chapel Hill
Responsible party
Sponsor
First posted
Aug 18, 2014
Start date
Oct 2014
Primary completion
May 2017
Completion
May 2017
Results posted
Jul 27, 2018
Last update
Jul 27, 2018

Study contacts

Ingeborg De Kok, DDS
principal investigator · University of North Carolina School of Dentistry

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion